Jason Wittes
Stock Analyst at Roth MKM
(3.18)
# 1,193
Out of 4,667 analysts
53
Total ratings
47.5%
Success rate
1.98%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences | Initiates: Buy | $11 | $4.07 | +170.27% | 1 | Nov 11, 2024 | |
| OFIX Orthofix Medical | Reiterates: Buy | $20 → $22 | $18.87 | +16.59% | 4 | Nov 8, 2024 | |
| GMED Globus Medical | Reiterates: Buy | $100 | $83.59 | +19.63% | 3 | Nov 6, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $2 | $0.46 | +336.87% | 1 | Sep 6, 2024 | |
| IRMD IRADIMED CORPORATION | Maintains: Buy | $65 → $60 | $52.08 | +15.21% | 2 | Aug 2, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $7.52 | +378.72% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $5.23 | +110.33% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.56 | +541.03% | 1 | Jun 26, 2024 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $100 | $103.44 | -3.33% | 1 | May 31, 2024 | |
| FBIO Fortress Biotech | Reiterates: Buy | $10 | $1.57 | +536.94% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $348 → $405 | $385.68 | +5.01% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.03 | +146.31% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.83 | +391.80% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $44.78 | +67.49% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $9.93 | +121.55% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $109.27 | +9.82% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $164.95 | +24.89% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $162.59 | -10.82% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $9.83 | +52.59% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $16.86 | +1,086.24% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $31.15 | -16.53% | 1 | Feb 22, 2017 |
TriSalus Life Sciences
Nov 11, 2024
Initiates: Buy
Price Target: $11
Current: $4.07
Upside: +170.27%
Orthofix Medical
Nov 8, 2024
Reiterates: Buy
Price Target: $20 → $22
Current: $18.87
Upside: +16.59%
Globus Medical
Nov 6, 2024
Reiterates: Buy
Price Target: $100
Current: $83.59
Upside: +19.63%
Allurion Technologies
Sep 6, 2024
Initiates: Buy
Price Target: $2
Current: $0.46
Upside: +336.87%
IRADIMED CORPORATION
Aug 2, 2024
Maintains: Buy
Price Target: $65 → $60
Current: $52.08
Upside: +15.21%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $7.52
Upside: +378.72%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $5.23
Upside: +110.33%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.56
Upside: +541.03%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $103.44
Upside: -3.33%
Fortress Biotech
May 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.57
Upside: +536.94%
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $385.68
Upside: +5.01%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.03
Upside: +146.31%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.83
Upside: +391.80%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $44.78
Upside: +67.49%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $9.93
Upside: +121.55%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $109.27
Upside: +9.82%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $164.95
Upside: +24.89%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $162.59
Upside: -10.82%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $9.83
Upside: +52.59%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $16.86
Upside: +1,086.24%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $31.15
Upside: -16.53%